The ability of malignancies to penetrate and spread in vitro and in vivo may be restricted through upregulating TIMP-3 and RECK, which could serve to be a target site in anti-tumor treatment (Fridman et al., 2017). The gene discussed is TIMP3; the disease is neoplasm.